Innovating for a healthier future
Discovering new therapeutics with rare & novel cannabinoids
Transforming the future of health through cannabinoid research
After decades of restriction, cannabinoids have emerged as a frontier of discovery – poised to revolutionize our understanding and enhancement of human health and wellness.
Using our proprietary platform Paragon™, FloraWorks is taking a modern approach to discovering and testing new cannabinoids.
Purchase minor cannabinoids
As the leader in minor cannabinoid supply and scientific research, we offer a diverse range of high-quality cannabinoids to meet the needs of a rapidly evolving industry. Explore our selection, including TruCBN™
The first and only clinically validated cannabinoid to improve sleep
Learn how you can leverage clinically backed claims to transform your brand into a market frontrunner and disrupt the OTC sleep aid market!
TruCBN™ in the news
Explore how TruCBN™ is redefining sleep wellness with clinically validated research, making headlines as the trusted, scientifically-backed choice for better rest.
The frontier of opportunity
At FloraWorks, we're driven to pioneer the next wave of cannabinoid discoveries through dynamic partnerships with academia and institutions worldwide.
Cannabinoids represent an under-researched class of small molecules — a fact which drastically increases the potential of new drug discoveries, therapeutic benefits & academic collaboration.
FloraWorks news and events
Discovering the Fountain of Youth for Brain Cells: A Groundbreaking Study by FloraWorks and The Salk Institute
The Remarkable Health Benefits of CBN: A Comprehensive Overview
Cannabinoid Biotech Leader FloraWorks to Present at Seed Showcase 2024 During J.P. Morgan Healthcare Conference
Stay ahead in the world of cannabinoid science
Join our exclusive email list for the latest insights and breakthroughs.